Abiopharma

Clinical trial NCT05082259 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-03-16 → 2026-12-01 3. primary completion date: 2026-03-16 → 2026-12-01

Clinical trial NCT07091019 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-11-15 → 2025-12-17 3. completion date: 2033-05-15 → 2033-04-20 4. primary completion date: 2033-05-15 → 2033-04-20

Clinical trial NCT05207709 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2027-03-01 → 2026-03-26 3. primary completion date: 2026-03-01 → 2026-03-26 4. enrollment: 456 → 61 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05385796 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-02-01 → 2023-12-10 3. primary completion date: 2024-02-01 → 2023-12-10 4. enrollment: 19 → 16 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07174726 updates: 1. completion date: 2030-12-15 → 2030-12-30 2. primary completion date: 2027-06-30 → 2029-12-31

Clinical trial NCT05716009 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2028-12-25 → 2025-07-16 3. primary completion date: 2027-12-25 → 2025-05-05 4. enrollment: 36 → 7 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05807841 updates: 1. completion date: 2029-06-30 → 2029-12-31 2. primary completion date: 2028-06-30 → 2028-12-31

Clinical trial NCT06100224 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-05-01 → 2026-07-01 3. primary completion date: 2026-05-01 → 2026-07-01 4. enrollment: 100 → 80 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07199634: start date: 2026-04-01 → 2026-08-01.

Clinical trial NCT06052995 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. start date: 2023-11-01 → 2024-10-15 3. completion date: 2025-02-01 → 2027-03-01 4. primary completion date: 2024-08-01 → 2026-10-01